The Glasgow Prognostic Score (GPS) and modified GPS (mGPS) are validated risk calculators based on CRP and albumin levels, demonstrated to predict survival in cancer patients, including gastric, lung and renal cancer [8, 10, 11, 17, 23–28] and for mGPS even in cancer patients independent of tumour site [29, 30]. The gene discussed is CRP; the disease is cancer.